| Code | 96854 | ||||||||||
| MA number | 09/0260/92-CS | ||||||||||
| Product Form: | tbl mnd 40x400 mg/400 mg (blis.PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Opella Healthcare Slovakia s.r.o., Slovakia | ||||||||||
| Therapeutic Class: | 09 - ANTACIDA (VRÁTANE ANTIULCEROSNYCH LIEČIV) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 8(3) application - known active substance |
| MA issued: | 08.04.1992 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Maalox žuvacie tablety_06_2023.pdf
|
| SPC: |
SPC_Maalox žuvacie tablety_06_2023.pdf
|
| Safety feature | No |
| Data update: | 05.03.2019 |
